Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceuticals – developed based on artificial platelet technology from ...

Human Platelet Lysate Market is projected to grow significantly through 2035, Driven by demand for stem cell therapy and regenerative medicine ...

HPL Electric & Power has shown a return of 0.58% in one day, 19.49% over the past month, and -14.43% in the last three months. Analyzing the technicals, the daily pivot level for the stock is set ...

New high-quality cell growth supplement for cell manufacturing applications including in regenerative medicine and cell therapies Human Platelet Lysate (HPL) offers a safer and sustainable ...